Public health issues, research on health systems, HTA and HEOR. We provide primary and secondary research on areas like health system, UHC, HTA, emerging diseases, NCDs, mental health, medical education, women’s health. Our vision is to help achieve a framework that ensures health coverage at every stage of life, with particular emphasis on primary health services, to ensure that all people receive quality health services without suffering financial hardship.
Pharma companies often reap the rewards of public spending. The U.S, every new drug approved by the FDA between 2010 and 2019 has relied on grants from the NIH. The companies sometimes turn around and charge the public exorbitant prices for the same drugs.
Previous estimates show that the global cost (health care expenditure and productivity losses) of physical inactivity was INT$ 67.5 billion annually.
Overdiagnosis and overuse of health care wastes an estimated 20% of health spending in high-income countries.
While we hope that mortality will return to pre-pandemic levels (and even start improving again), sustained excess deaths in England and elsewhere in 2022 suggests we have not fully bounced back from the mortality impact of the pandemic, and the path to recovery remains uncertain.
Out-of-pocket expenditure mainly consists of direct costs such as doctor’s consultation fees, medicine charges, laboratory, and other diagnostic charges paid by households.
NOTICE, NAME and REFOCUS
